BACKGROUND: Heart donor availability continues to limit cardiac transplantation rates and many donor hearts are not transplanted because of left ventricular dysfunction. The aim of this study was to determine whether intensive donor management results in improved left ventricular systolic function as measured by serial echocardiography. METHODS: Using the California Transplant Donor Network Database, all donors who underwent serial echocardiography during donor management (from 1996 to 2000) were identified. The study includes those donors with ejection fractions <50% or regional wall-motion abnormalities shown on the initial echocardiogram. The database provides clinical data describing donor characteristics, treatments, and recipient outcomes. The mean ejection fractions at the first and second echocardiograms were compared using the Wilcoxon signed rank test. RESULTS: In 13 of 16 subjects, initial ejection fractions were <50% and improved in 12 subjects after intensive donor management. Seventy-five percent of the donors received high-dose corticosteroids, 15 of 16 received dopamine, and none received thyroid hormone. In 12 subjects, the donor hearts were transplanted with a survival rate of 92% at an average follow-up of 16 months. CONCLUSIONS: This pilot study indicates that in some cases, intensive donor management is associated with improved donor left ventricular function. Prospective studies are indicated to determine the predictors of improved donor left ventricular dysfunction and of recipient survival when sub-optimal hearts are transplanted.
BACKGROUND: Heart donor availability continues to limit cardiac transplantation rates and many donor hearts are not transplanted because of left ventricular dysfunction. The aim of this study was to determine whether intensive donor management results in improved left ventricular systolic function as measured by serial echocardiography. METHODS: Using the California Transplant Donor Network Database, all donors who underwent serial echocardiography during donor management (from 1996 to 2000) were identified. The study includes those donors with ejection fractions <50% or regional wall-motion abnormalities shown on the initial echocardiogram. The database provides clinical data describing donor characteristics, treatments, and recipient outcomes. The mean ejection fractions at the first and second echocardiograms were compared using the Wilcoxon signed rank test. RESULTS: In 13 of 16 subjects, initial ejection fractions were <50% and improved in 12 subjects after intensive donor management. Seventy-five percent of the donors received high-dose corticosteroids, 15 of 16 received dopamine, and none received thyroid hormone. In 12 subjects, the donor hearts were transplanted with a survival rate of 92% at an average follow-up of 16 months. CONCLUSIONS: This pilot study indicates that in some cases, intensive donor management is associated with improved donor left ventricular function. Prospective studies are indicated to determine the predictors of improved donor left ventricular dysfunction and of recipient survival when sub-optimal hearts are transplanted.
Authors: Xenia I Borbely; Vijay Krishnamoorthy; Shan Modi; Ali Rowhani-Rahbar; Edward Gibbons; Michael J Souter; Monica S Vavilala Journal: Neurocrit Care Date: 2015-08 Impact factor: 3.210
Authors: Vijay Krishnamoorthy; Xenia Borbely; Ali Rowhani-Rahbar; Michael J Souter; Edward Gibbons; Monica S Vavilala Journal: Pediatr Crit Care Med Date: 2015-05 Impact factor: 3.624
Authors: Elizabeth A Swanson; Tony Adams; Madhukar S Patel; Salvador De La Cruz; Michael Hutchens; Kiran Khush; Mitchell B Sally; Claus U Niemann; Tahnee Groat; Darren J Malinoski Journal: J Am Coll Surg Date: 2020-06-17 Impact factor: 6.113
Authors: Kiran K Khush; Rebecca Menza; John Nguyen; Benjamin A Goldstein; Jonathan G Zaroff; Barbara J Drew Journal: Circ Heart Fail Date: 2012-05-21 Impact factor: 8.790
Authors: K K Khush; L Pawlikowska; R L Menza; B A Goldstein; V Hayden; J Nguyen; H Kim; A Poon; A Sapru; M A Matthay; P Y Kwok; W L Young; L A Baxter-Lowe; J G Zaroff Journal: Am J Transplant Date: 2012-09-20 Impact factor: 8.086